市场调查报告书
商品编码
1379198
2023-2028 年按产品、材料、最终用户(製药和生物技术公司、合约製造组织、合约研究组织、学术和研究机构)和地区分類的药品瓶盖和密封件市场报告Pharmaceutical Caps and Closures Market Report by Product, Material, End User (Pharmaceutical and Biotechnology Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic and Research Institutes), and Region 2023-2028 |
2022年全球药品瓶盖和瓶盖市场规模达34亿美元。展望未来, IMARC Group预计到 2028 年市场规模将达到 57 亿美元,2022-2028 年复合年增长率 (CAGR) 为 9.0%。癌症、糖尿病、气喘和心血管疾病等慢性和急性疾病的盛行率不断上升,对安全有效包装的需求不断增加,以及儿童安全包装解决方案的推出是推动市场发展的一些关键因素。
药品瓶盖和封口是气密密封产品,可保护药品免受灰尘、湿气和不利气候条件的影响。它们由不同的金属材料和聚合物製成,例如高密度聚丙烯(HDPP)和聚乙烯。它们可以保护产品免受环境和微生物的破坏,从而帮助产品长时间保持新鲜。它们还增强了产品的美感,并使从一处运输到另一处时的处理变得方便。此外,它们还可以透过避免微生物侵袭和污染的机会,帮助最大限度地减少浪费并延长包装药物的保质期。因此,全球对药品瓶盖和瓶盖的需求不断增加。
由于久坐的生活方式、老年人口的增加和不健康的饮食模式,各种急慢性疾病的盛行率增加,例如高血压、糖尿病、气喘、肥胖、慢性阻塞性肺病、肌肉骨骼疾病和牙齿问题。这是推动全球对瓶盖和瓶盖等药品包装解决方案需求的关键因素之一。对安全有效的包装解决方案不断增长的需求也鼓励了药品瓶盖和密封件市场的创新。除此之外,对儿童安全包装解决方案的需求不断增长,以防止儿童意外食用,这是支持市场成长的另一个主要因素。此外,随着个人支出能力的增加以及医院、门诊手术中心 (ASC) 和其他医疗中心的扩张,全球对药品的需求正在增加。此外,产业投资者越来越关注利用先进製造技术生产高精度、高效率的轻质瓶盖和瓶盖,这提供了良好的市场前景。除此之外,用塑胶製造的瓶盖和密封件由于经济、耐用且耐腐蚀而在製药业获得了巨大的吸引力。此外,领先的市场参与者正在开发具有卓越耐化学性能的不同形状和尺寸的客製化产品,以满足最终用户的要求。他们还专注于开发由可回收或可生物降解材料製成的可持续封闭解决方案,以减少对环境的影响和产品开发成本,预计这将推动市场成长。
The global pharmaceutical caps and closures market size reached US$ 3.4 Billion in2022. Looking forward, IMARC Group expects the market to reach US$ 5.7 Billion by 2028 exhibiting a growth rate (CAGR) of 9.0% during 2022-2028. The growing prevalence of chronic and acute conditions, such as cancer, diabetes, asthma, and cardiovascular diseases, rising need for safe and effective packaging, and the introduction of child-proof packaging solution represent some of the key factors driving the market.
Pharmaceutical caps and closures are air-tight sealing products that protect pharmaceutical items from dust, moisture, and unfavorable climatic conditions. They are made up of different metallic materials and polymers, such as high-density polypropylene (HDPP) and polyethylene. They help keep the content fresh for an extended period by protecting products from environmental and microbiological spoilage. They also enhance product aesthetics and make handling convenient during transportation from one place to another. In addition, they assist in minimizing wastage and increasing the shelf-life of packed medicines by averting the chances of microbial attacks and contamination. As a result, the demand for pharmaceutical caps and closures is increasing across the globe.
Due to sedentary lifestyles, rising geriatric population, and unhealthy dietary patterns, there is an increase in the prevalence of various acute and chronic conditions, such as hypertension, diabetes, asthma, obesity, COPD, musculoskeletal disorders, and dental problems. This represents one of the key factors catalyzing the demand for pharmaceutical packaging solutions like caps and closures across the globe. The escalating demand for safe and effective packaging solutions is also encouraging innovations in the pharmaceutical caps and closures market. Along with this, the rising need for child-proof packaging solutions to prevent kids from accidental consumption is another major factor supporting the growth of the market. Furthermore, the demand for pharmaceutical products is increasing worldwide with the increasing expenditure capacity of individuals and the expansion of hospitals, ambulatory surgical centers (ASCs), and other healthcare centers. Moreover, rising focus of industry investors on utilizing advanced manufacturing techniques for producing lightweight caps and closures with high precision and efficiency is offering a favorable market outlook. Apart from this, caps and closures manufactured with plastic are gaining immense traction in the pharmaceutical industry as they are economical, durable, and resistant to corrosion. Furthermore, leading market players are developing customized products in different shapes and sizes with superior chemical resistance properties to meet end-user requirements. They are also focusing on the development of sustainable closure solutions made from recyclable or biodegradable materials to reduce the environmental impact and product development costs, which is anticipated to propel the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global pharmaceutical caps and closures market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product, material, and end user.
Screw-on Caps
Dispensing Caps
A detailed breakup and analysis of the pharmaceutical caps and closures market based on the product has also been provided in the report. This includes screw-on caps and dispensing caps.
PP
HDPE
LDPE
The report has provided a detailed breakup and analysis of the pharmaceutical caps and closures market based on the material. This includes PP, HDPE, and LDPE.
Pharmaceutical and Biotechnology Companies
Contract Manufacturing Organizations (CMO)
Contract Research Organizations (CRO)
Academic and Research Institutes
A detailed breakup and analysis of the pharmaceutical caps and closures market based on the end user has also been provided in the report. This includes pharmaceutical and biotechnology companies, contract manufacturing organizations (CMO), contract research organizations (CRO), and academic and research institutes.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for pharmaceutical caps and closures on account of the highly advanced and robust healthcare infrastructure, presence of well-established pharmaceutical industry, increasing investment in the healthcare industry, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global pharmaceutical caps and closures market. Detailed profiles of all major companies have been provided. Some of the companies covered include Amcor PLC, Aptar Group Inc., Bericap GmbH and Co. KG, Berry Global Group Inc., Closure Systems International Inc., Comar LLC, MJS Packaging, Pano Cap Canada Ltd, Saudi Basic Industries Corporation (Saudi Arabian Oil Co.), Tecnocap S.p.A., United Caps Luxembourg S.A., etc. Kindly note that this only represents a partial list of companies and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.